Congenital malformations of anterior segment of eye

Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q13 Cause of death: ICD-10 — Q13 2 out of 7 registries used, show all original rules.	298
4. Check minimum number of events None	298
5. Include endpoints None	298
6. Filter based on genotype QC (FinnGen only)	298

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q1
Name in latin: Malformationes congenitae segmenti anterioris oculi

NAME	Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q13
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q13
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital malformations of anterior segment of eye based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3928	2171	1751
Only index persons	3225	1828	1397
Unadjusted period prevalence (%)
Whole population	0.06	0.06	0.05
Only index persons	0.06	0.07	0.05
Median age at first event (years)
Whole population	17.73	23.82	10.13
Only index persons	25.88	30.67	19.61

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	298	199	99
Unadjusted period prevalence (%)	0.06	0.07	0.04
Median age at first event (years)	40.86	39.43	43.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
275: Matched controls
2751

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q13.2

ICD-10 Finland

Other congenital malformations of iris

+∞

292.7

226

Q13.0

ICD-10 Finland

Coloboma of iris

+∞

23.3

Q13.1

ICD-10 Finland

Absence of iris

+∞

13.7

H57.0

ICD-10 Finland

Anomalies of pupillary function

42.3

13.3

Q13.4

ICD-10 Finland

Other congenital corneal malformations

+∞

10.5

XCK00

NOMESCO Finland

Perimetry

4.3

8.5

Q14.8

ICD-10 Finland

Other congenital malformations of posterior segment of eye

+∞

8.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

8.1

113

668

G90.2

ICD-10 Finland

Horner syndrome

46.3

7.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

7.7

247

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.2

7.6

133

S01ED01

ATC

timolol; ophthalmic

7.2

7.4

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

71.4

6.5

ZXA10

NOMESCO Finland

Bilateral

2.4

6.3

273

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

151

1120

1.71

4.88

8.2

7.6

1.2

mmol/l

0.16

122

952

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

4.42

4.87

1.6

1.4

—

nmol/l

—

(42870588) Differential panel, method unspecified - Blood

117

822

1.70

4.54

7.6

6.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.99

4.30

1.6

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

241

2.02

4.17

3.6

2.0

368.0

368.2

nmol/l

0.00

225

(3024561) Albumin [Mass/volume] in Serum or Plasma

131

966

1.64

4.13

5.2

4.7

36.6

36.3

g/l

0.21

124

902

(3002030) Lymphocytes/100 leukocytes in Blood

159

1245

1.59

3.82

7.8

6.3

30.1

29.2

0.38

154

1170

(3025159) Blasts/100 leukocytes in Blood

179

2.08

3.67

6.5

4.8

0.0

0.49

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

136

1036

1.58

3.62

7.9

7.3

1.2

mmol/l

0.05

129

951

(3022096) Basophils/100 leukocytes in Blood

149

1162

1.56

3.56

7.8

6.4

0.7

0.12

144

1085

(3019069) Monocytes/100 leukocytes in Blood

154

1211

1.56

3.54

8.1

6.5

8.2

8.4

0.39

149

1138

(3006504) Eosinophils/100 leukocytes in Blood

153

1204

1.56

3.49

7.9

6.3

3.1

2.8

1.07

148

1123

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

215

1834

1.62

3.40

8.7

7.1

78.4

80.3

u/l

0.26

208

1723

(3021440) Promyelocytes/100 leukocytes in Blood

187

1.99

3.27

6.5

4.8

0.1

0.37

(3002179) Metamyelocytes/100 leukocytes in Blood

180

2.00

3.26

6.5

4.4

0.6

0.5

0.17

(3018010) Neutrophils/100 leukocytes in Blood

155

1236

1.53

3.25

7.4

6.1

56.2

56.3

0.01

149

1166

(3019198) Lymphocytes [#/volume] in Blood

163

1327

1.50

3.01

7.4

6.2

2.2

1.9

e9/l

1.01

149

1189

(3000494) Fungus identified in Specimen by Culture

277

1.78

3.00

1.6

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

345

1.69

2.86

2.1

1.9

—

(3001604) Monocytes [#/volume] in Blood

158

1287

1.48

2.86

7.3

6.2

0.6

e9/l

0.34

140

1122

(3013115) Eosinophils [#/volume] in Blood

162

1329

1.48

2.81

7.4

6.6

0.2

e9/l

2.14

146

1182

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.00

2.79

1.0

1.2

—

(3006315) Basophils [#/volume] in Blood

158

1291

1.48

2.79

7.3

6.2

0.0

e9/l

0.02

140

1126

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

129

1015

1.48

2.75

2.8

2.3

75.9

75.1

nmol/l

0.12

121

918

(3017181) Myelocytes/100 leukocytes in Blood

202

1.83

2.62

6.6

4.5

1.6

0.7

0.65

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

233

1.78

2.62

1.9

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

104

792

1.48

2.58

2.4

3.5

26.8

30.2

u/l

1.04

753

(3015377) Calcium [Moles/volume] in Serum or Plasma

103

784

1.48

2.55

2.9

3.2

2.3

2.4

mmol/l

0.29

696

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

236

1.75

2.51

2.1

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

4.45

2.49

1.1

1.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

715

1.48

2.48

3.3

2.3

56.2

53.6

u/l

0.44

656

(3048689) Calprotectin [Mass/mass] in Stool

342

1.63

2.47

2.3

2.5

126.5

122.6

ug/g

0.02

264

(3009508) Creatinine [Moles/volume] in Urine

681

1.48

2.44

3.3

2.8

6.9

7.8

mmol/l

1.09

575

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

105

809

1.46

2.43

4.1

3.6

24.9

33.0

ng/l

0.57

510

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.33

2.38

4.8

7.8

—

(3018418) pH of Serum or Plasma

686

1.47

2.34

5.4

3.8

7.4

0.10

132

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.62

2.30

4.3

2.5

—

(3012516) Albumin [Mass/volume] in Urine

583

1.48

2.25

3.1

52.5

45.8

mg/l

0.10

383

(3020682) Albumin/Creatinine [Ratio] in Urine

610

1.47

2.25

3.8

3.9

9.9

8.0

mg/mmol

0.14

381

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

216

1916

1.46

2.24

5.1

3.9

14.5

14.7

pmol/l

0.36

201

1741

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

436

1.53

2.22

1.4

1.7

496.6

449.2

pmol/l

0.56

371

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

244

2221

1.54

2.20

13.9

11.3

87.3

ml/min/173m2

0.01

191

1790

(3032080) INR in Blood by Coagulation assay

107

842

1.42

2.17

11.4

7.9

1.2

inr

0.07

280

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.11

2.16

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

2.76

2.12

3.7

3.4

1.3

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

256

1.65

2.12

2.0

1.8

—

(3002032) Base excess in Venous blood by calculation

218

1.69

2.05

5.0

5.9

1.4

1.8

mmol/l

0.20

164

(3012544) pH of Venous blood

226

1.67

2.05

5.1

5.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

251

2310

1.55

2.03

5.7

4.5

1.9

2.4

mu/l

0.44

231

2120

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.69

2.03

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

3.13

2.03

8.5

1.5

33.1

33.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.62

1.94

2.9

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

674

1.41

1.90

1.4

1.3

0.5

0.9

u/ml

1.75

179

(3038177) Helicobacter pylori Ab [Presence] in Serum

2.70

1.88

1.3

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

161

1.74

1.86

8.9

7.1

2.8

1.4

mmol/l

2.15

121

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.58

1.84

1.8

2.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.32

1.83

4.4

2.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

171

1484

1.36

1.83

9.8

9.5

4.1

4.0

e9/l

0.27

156

1304

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.22

1.80

1.4

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.39

1.80

1.1

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

189

1670

1.36

1.77

5.4

4.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

148

1.75

1.77

1.7

1.5

17.0

22.9

iu/l

0.46

123

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

243

2240

1.46

1.76

4.0

3.6

1.3

1.2

mmol/l

0.28

225

2066

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

3.38

1.75

2.0

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

574

1.41

1.74

2.7

3.6

624.7

1009.0

ng/l

1.61

488

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.71

1.73

1.1

—

(3023419) Bacteria identified in Sputum by Culture

2.71

1.73

5.5

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

161

1392

1.34

1.73

4.9

5.1

6.5

mmol/l

0.12

154

1273

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

267

2512

1.60

1.72

17.6

12.7

19.9

21.8

mg/l

0.44

220

1905

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.89

1.72

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.89

1.72

2.2

3.4

23.2

25.2

umol/l

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

145

1238

1.33

1.68

6.6

6.5

11.2

11.4

umol/l

0.04

140

1159

(40768797) Stomach Pathology biopsy report

314

1.51

1.68

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

251

2335

1.48

1.66

4.2

4.0

1.5

mmol/l

0.02

232

2158

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.54

1.61

3.3

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.93

1.58

2.1

2.2

—

(3023368) Bacteria identified in Blood by Culture

577

1.38

1.53

5.7

4.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.37

1.53

1.4

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

254

1.52

1.50

4.8

3.3

1.6

1.8

0.23

231

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

251

2349

1.43

1.47

4.4

4.0

4.7

mmol/l

0.54

233

2185

(3021901) Oxygen saturation in Capillary blood

2.41

1.47

1.9

3.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.54

1.46

1.3

—

(3042631) Mycobacterium sp identified in Specimen

2.45

1.40

3.9

3.3

—

(3025941) Bacteria identified in Stool by Culture

151

1.64

1.40

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

2.64

1.37

2.8

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.64

1.37

1.0

1.2

—

(3011648) Oxygen content in Venous blood

2.97

1.36

4.0

14.9

11.9

12.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.18

1.35

1.1

1.0

—

(40758558) Short blood count panel - Blood

635

1.33

1.34

6.8

7.5

—

(3026008) Bacteria identified in Urine by Culture

692

1.32

4.0

2.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

296

1.45

1.31

2.8

2.1

22.8

23.3

0.08

258

(40761511) CBC panel - Blood by Automated count

273

2608

1.56

1.31

16.3

11.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

656

1.32

1.31

2.0

2.2

181.7

178.6

u/l

0.02

618

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

4.6

1.4

—

(40768804) Tissue Pathology biopsy report

114

970

1.28

1.27

2.1

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

274

2623

1.55

1.26

12.2

9.7

26.7

26.1

u/l

0.13

268

2532

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

109

923

1.29

1.26

5.5

3.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

422

1.37

1.26

1.3

69.3

27.6

iu/ml

0.58

133

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.26

1.25

3.3

1.5

—

(3021589) Normoblasts [#/volume] in Blood

133

1156

1.27

1.25

12.2

9.5

0.0

e9/l

0.82

107

947

(3041096) Erythrocytes [Presence] in Urine by Automated

679

1.31

1.24

4.1

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.94

1.24

1.6

1.4

264.4

321.3

ug/g

—

(4198724)

2.66

1.22

1.8

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

252

2381

1.38

1.20

4.8

4.4

2.8

mmol/l

0.19

231

2191

(3029937) Albumin [Presence] in Urine by Test strip

657

1.30

1.16

6.3

3.7

0.0

estimate

0.50

254

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.72

1.16

1.3

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

132

1154

1.26

1.16

3.2

2.7

100.8

94.2

ug/l

0.19

121

1060

(3026782) Osmolality of Urine

474

1.33

1.15

3.9

2.6

541.8

549.2

mosm/kgh2o

0.09

403

(3019060) Gas panel - Arterial blood

127

1.62

1.14

6.8

8.6

—

(3000850) Epithelial cells [#/volume] in Urine

493

1.33

1.13

3.8

2.4

10.3

7.6

e6/l

0.46

436

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.36

1.13

3.6

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

227

2121

1.29

1.10

5.4

5.1

39.3

39.0

mmol/mol

0.22

211

1990

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.85

1.10

2.6

1.7

—

(1616796) Gas panel - Central venous blood

1.98

1.09

11.1

2.5

—

(3044889) 12 lead EKG panel

176

1599

1.25

1.07

3.9

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

154

1.53

1.07

1.7

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.08

1.03

3.6

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.90

1.01

9.6

4.1

52.8

57.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.02

1.00

3.6

8.1

69.7

67.1

—

(3022313) Gas panel - Capillary blood

132

1.55

1.00

11.5

7.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

558

1.28

0.99

2.8

2.9

326.9

5365.4

umol/l

2.27

481

(3027315) Oxygen [Partial pressure] in Blood

1.86

0.99

11.1

2.7

8.9

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.86

0.99

11.1

2.7

4.8

5.1

kpa

—

(3013512) EKG study

597

1.27

0.97

4.7

3.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.75

0.93

3.0

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

102

0.48

0.91

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

102

0.48

0.91

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.88

0.88

3.3

1.5

—

(40761536) Microorganisms panel - Urine sediment

222

1.39

0.88

5.9

3.6

—

(3015736) pH of Urine

107

941

1.21

0.84

4.5

3.2

—

(3037522) Nuclear Ab [Titer] in Serum

340

1.31

0.83

1.8

1.4

296.5

464.8

titre

0.94

(3007164) IgA [Mass/volume] in Serum or Plasma

608

1.24

0.83

1.9

1.4

2.2

2.3

g/l

0.14

367

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.72

0.83

1.0

1.2

0.6

5.1

u/ml

—

(44790047)

1.89

0.82

1.2

1.8

—

(44790048)

1.89

0.82

1.2

1.8

—

(44806118)

1.89

0.82

1.2

1.8

—

(44790049)

1.89

0.82

1.2

1.8

—

(3000991) Gas panel - Venous blood

199

1.39

0.81

8.0

9.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

396

1.28

0.81

3.1

3.8

463.1

266.0

ng/l

0.21

274

(40768441) Liver Pathology biopsy report

0.00

0.79

0.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.79

0.0

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

166

1.42

0.78

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.78

0.76

2.3

4.5

—

(3019150) Specific gravity of Urine by Refractometry

539

1.24

0.76

5.6

3.4

1.0

kg/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.67

0.76

2.7

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

196

1836

1.20

0.75

5.3

4.0

8.8

10.6

mm/h

2.40

188

1677

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.10

0.75

1.0

—

(1761868) Lipid panel - Serum or Plasma

104

922

1.20

0.74

2.8

2.6

—

(3002256) Pathology report gross observation

292

1.30

0.74

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

106

0.56

0.74

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

420

1.26

0.74

1.3

24.2

8.3

u/ml

0.47

163

(3009466) Valproate [Moles/volume] in Serum or Plasma

1.81

0.73

4.4

4.8

406.9

377.2

umol/l

—

(3024928) Oxygen saturation in Venous blood

1.81

0.73

3.3

8.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.69

0.73

1.1

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

239

1.33

0.73

1.5

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

375

1.27

0.72

4.1

4.4

24.7

22.0

0.37

181

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.60

0.72

1.2

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.77

0.71

1.6

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.94

0.71

1.2

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.57

0.70

1.9

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

177

1649

1.18

0.70

3.5

3.2

36.9

41.5

u/l

0.68

165

1552

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

205

1.35

0.70

1.3

174.0

156.5

iu/ml

0.11

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

110

1.48

0.70

1.4

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

131

1192

1.18

0.69

5.0

3.4

0.0

estimate

0.00

254

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.68

0.69

1.0

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

239

2289

1.22

0.68

4.7

4.1

5.8

mmol/l

0.16

215

2101

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.51

0.68

1.5

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

224

1.33

0.68

4.5

3.3

—

(3000492) Spirometry study

224

1.33

0.68

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

242

1.31

0.67

1.9

—

(4062490)

1.80

0.66

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

131

1196

1.17

0.65

6.3

4.6

0.0

estimate

0.00

256

(3023183) Ammonium ion [Moles/volume] in Plasma

1.60

0.65

1.9

2.7

28.0

36.7

umol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

455

1.23

0.65

2.0

2.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

173

1.36

0.64

11.1

11.2

25.9

25.1

mmol/l

0.52

173

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.65

0.62

1.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

300

1.27

0.62

2.1

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

1.68

0.61

2.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

210

1.31

0.61

4.7

4.5

2.4

27.4

ug/l

0.68

176

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

469

1.21

0.59

5.2

4.8

2.0

2.1

ug/l

0.13

413

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

1.44

0.59

11.9

14.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

125

1146

1.16

0.58

4.0

4.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

133

1.38

0.56

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1.56

0.56

2.1

2.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

122

0.65

0.56

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

122

0.65

0.56

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

122

0.65

0.56

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

122

0.65

0.56

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1.52

0.55

1.8

1.3

—

2.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.49

0.54

1.1

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.47

0.53

1.9

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.47

0.53

1.8

1.3

—

2.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

271

1.24

0.51

1.8

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.40

0.51

2.4

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

365

1.21

0.50

1.7

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.46

0.48

1.2

1.1

—

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

864

1.15

0.48

2.1

1.8

90.8

97.0

pmol/l

0.77

436

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

373

0.81

0.48

2.9

2.6

1.3

0.9

e6/l

0.41

207

(3037121) Protein [Mass/volume] in Urine

1.43

0.47

7.9

3.2

0.2

g/l

—

(3009261) Glucose [Presence] in Urine by Test strip

130

1209

1.13

0.47

5.0

3.4

0.0

estimate

0.00

247

(3019309) Folate [Moles/volume] in Red Blood Cells

386

1.20

0.47

1.8

1.6

1084.8

1188.4

nmol/l

0.29

287

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

274

0.79

0.46

5.7

6.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.43

0.43

2.3

1.9

0.6

4.1

ug/l

0.50

(3003694) ABO and Rh group [Type] in Blood

766

0.87

0.43

1.7

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

754

1.14

0.43

2.4

—

(3021788) Differential panel - Synovial fluid

1.62

0.43

1.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.65

0.43

1.3

1.2

—

(3020891) Body temperature

1.40

0.43

1.7

5.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.40

0.43

1.7

1.4

—

(4010399)

159

1.28

0.41

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

0.00

0.41

0.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.41

0.0

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

189.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.41

0.0

2.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.41

0.0

2.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.34

0.40

1.1

1.3

—

(3022145) Colonoscopy Study observation

270

1.21

0.40

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.40

0.0

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

1.5

—

0.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

106

1.34

0.40

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

160

1.27

0.39

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1.42

0.39

1.7

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

115

1.32

0.39

2.1

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

623

1.14

0.39

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.39

0.0

4.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

197

1.24

0.39

1.9

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

643

1.14

0.39

1.5

1.7

1.3

mmol/l

0.53

555

(3019225) pH of Specimen

188

1.24

0.39

3.7

4.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.36

0.38

1.9

1.6

—

(3027944) Amphetamines [Presence] in Urine

143

1.28

0.38

1.5

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.36

0.37

2.0

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.35

0.36

1.9

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

144

1.27

0.36

2.2

15563.1

2879.3

u/l

—

(3000764) Benzodiazepines [Presence] in Urine

144

1.27

0.36

1.5

1.6

—

(3027008) Opiates [Presence] in Urine

144

1.27

0.36

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

265

0.82

0.36

1.4

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.44

0.35

6.2

4.2

—

(3025130) Human papilloma virus identified in Specimen

1.44

0.35

2.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

832

1.12

0.35

4.7

3.0

—

(3037756) Immunofixation for Serum or Plasma

1.40

0.35

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.40

0.35

1.7

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

532

1.14

0.35

2.1

2.3

0.8

1.2

mg/l

1.59

411

(3028300) Cannabinoids [Presence] in Urine

145

1.26

0.34

1.5

1.6

—

(3045424) Erythrocytes [Presence] in Urine

1.34

0.34

1.0

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

718

1.12

0.33

4.2

3.0

15.4

44.3

e6/l

2.06

556

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

358

0.85

0.33

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

507

1.13

0.31

1.6

1.4

21.7

21.0

nmol/l

0.13

429

(3044290) Cell count panel - Cerebral spinal fluid

1.33

0.31

1.6

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.33

0.31

1.9

1.3

—

0.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

129

1.25

0.31

4.3

4.9

131.2

129.8

g/l

0.08

124

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.33

0.28

1.3

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

405

1.13

0.28

2.0

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

638

1.11

0.27

7.5

4.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

128

0.77

0.27

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.29

0.26

1.8

—

(40761535) Cells panel - Urine sediment

190

0.83

0.24

7.6

3.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

358

0.88

0.24

3.1

2.8

1.6

2.6

e6/l

0.86

193

(4035726)

209

1.16

0.23

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.29

0.23

1.4

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.29

0.23

1.8

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.26

0.23

1.2

1.1

—

(3003338) MCHC [Mass/volume]

214

2188

0.92

0.22

19.4

16.5

333.2

332.7

g/l

0.41

214

2177

(4306422)

1.25

0.22

1.2

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1.25

0.22

1.0

1.5

7.0

6.8

mmol/l

—

(36660697) Celiac disease serology panel - Serum

229

1.15

0.22

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

135

0.81

0.22

1.2

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

412

1.11

0.22

2.7

2.5

2.4

mmol/l

0.49

361

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.19

0.21

1.6

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

102

0.78

0.21

1.4

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.4

—

(3014271) Vancomycin [Susceptibility]

0.00

0.21

0.0

2.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

149.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.4

—

(3017569) Oxygen content in Arterial blood

0.00

0.21

0.0

7.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.3

—

0.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

375

0.89

0.21

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.20

0.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3042936) Bacteria identified in Isolate by Culture

318

1.11

0.20

2.5

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

122

0.81

0.19

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

640

1.08

0.19

1.5

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

591

1.08

0.19

2.4

2.2

2.8

3.0

mg/l

0.48

513

(3016879) Cocaine [Presence] in Urine

137

1.18

0.19

1.5

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.19

0.18

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

119

1.19

0.18

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

192

1877

1.06

0.18

3.4

3.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.11

0.17

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

1.16

0.16

3.8

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

469

1.08

0.16

1.7

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.14

0.15

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.11

0.15

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.19

0.14

1.5

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.78

0.14

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

530

1.07

0.14

1.9

1.7

—

(3018095) Leukocytes [#/volume] in Urine

858

1.05

0.13

4.8

3.6

115.1

52.4

e6/l

0.29

587

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

219

0.91

0.11

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

186

0.91

0.09

2.1

2.3

—

19.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.11

0.09

5.5

3.4

—

3.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

224

1.08

0.08

2.8

2.9

0.2

g/l

0.05

210

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.82

0.08

1.0

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.78

0.08

3.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.08

0.08

1.0

2.0

4.2

3.7

mmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

550

0.96

0.08

5.7

3.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.84

0.07

1.5

4.4

3.4

3.9

mmol/l

—

(3003396) Base excess in Arterial blood by calculation

235

1.07

0.07

8.8

10.1

2.0

1.1

mmol/l

0.71

186

(3030467) Casts [#/volume] in Urine by Automated count

650

1.04

0.07

4.2

2.9

0.2

0.4

e6/l

0.68

491

(1002224) Polysomnography panel

112

0.89

0.07

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

196

1.08

0.07

1.8

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.86

0.07

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.07

0.07

1.1

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

131

0.91

0.05

3.4

2.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

233

2346

0.97

0.05

17.1

13.7

39.8

40.1

0.30

178

1804

(40768443) Skin Pathology biopsy report

101

1.09

0.04

1.5

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

149

0.94

0.03

1.1

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

270

1.04

0.03

2.6

2.9

0.7

0.8

ug/l

0.15

180

(3045414) Leukocytes [Presence] in Urine

102

1.08

0.03

1.6

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

580

0.98

0.02

2.6

2.4

—

(3011288) Drugs identified in Urine by Screen method

1.08

0.02

2.4

2.0

—

(3008898) HLA-B27 [Presence]

127

0.94

0.01

1.4

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

104

1.06

0.01

1.5

1.4

—

(3036489) Thrombin time

108

1.02

0.00

1.1

4.7

23.2

22.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

258

1.01

0.00

4.3

4.2

30.0

31.6

0.43

168

(3004716) Salmonella sp identified in Stool by Organism specific culture

151

0.99

0.00

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

105

1.05

0.00

2.7

3.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

185

1.03

0.00

6.2

2.9

65.7

68.7

ml/min/173m2

0.16

(36304419) Bacteria [Presence] in Urine

645

0.99

0.00

4.4

2.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.98

0.00

2.8

1.3

1.8

2.8

ug/l

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.3

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3035880) pH of Pleural fluid

0.00

0.0

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

24.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.1

—

7.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.89

0.00

1.0

1.3

0.7

0.8

nmol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.0

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.7

—

1.2

—

(40768793) Breast Pathology biopsy report

0.94

0.00

1.7

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

2.5

—

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(4133840)

0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

70.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.94

0.00

1.6

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.0

2.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.94

0.00

1.4

1.3

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.6

—

(4034850)

0.92

0.00

8.7

10.1

—

(3022621) pH of Urine by Test strip

140

1.00

0.00

3.6

2.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

7.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

157.2

—

(44806420)

0.00

0.0

2.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

13.8

—

0.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.94

0.00

1.6

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.99

0.00

1.1

2.0

429.0

420.4

mg/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE	1.16 [0.95, 1.41]	0.138
Birth year	0.997 [0.99, 1.01]	0.48

During the follow-up period (1.1.1998 — 31.12.2019), 111 out of 2105 females with Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE died.

Males

Parameter	HR [95% CI]	p-value
Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE	1.031 [0.81, 1.31]	0.799
Birth year	0.984 [0.97, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 104 out of 1688 males with Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE.

N-year risk	Females	Males
1	0.12%	0.199%
5	0.737%	1.156%
10	1.857%	2.918%
15	3.662%	5.273%
20	6.114%	8.716%

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE – Congenital malformations of anterior segment of eye

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital malformations of anterior segment of eye

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints